Decorin Antagonizes IGF Receptor I (IGF-IR) Function by Interfering with IGF-IR Activity and Attenuating Downstream Signaling
出版年份 2011 全文链接
标题
Decorin Antagonizes IGF Receptor I (IGF-IR) Function by Interfering with IGF-IR Activity and Attenuating Downstream Signaling
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 286, Issue 40, Pages 34712-34721
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2011-08-13
DOI
10.1074/jbc.m111.262766
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Decorin Suppresses Prostate Tumor Growth through Inhibition of Epidermal Growth Factor and Androgen Receptor Pathways
- (2015) Yunping Hu et al. NEOPLASIA
- The Insulin-Like Growth Factor Receptor I Promotes Motility and Invasion of Bladder Cancer Cells through Akt- and Mitogen-Activated Protein Kinase-Dependent Activation of Paxillin
- (2010) David Metalli et al. AMERICAN JOURNAL OF PATHOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
- (2010) Achilleas D. Theocharis et al. FEBS Journal
- Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans
- (2010) Renato V. Iozzo et al. FEBS Journal
- Decorin Antagonizes Met Receptor Activity and Down-regulates β-Catenin and Myc Levels
- (2010) Simone Buraschi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
- (2010) Renato V. Iozzo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- IGF-IR Internalizes with Caveolin-1 and PTRF/Cavin in Hacat Cells
- (2010) Barbara Salani et al. PLoS One
- Proepithelin Regulates Prostate Cancer Cell Biology by Promoting Cell Growth, Migration, and Anchorage-Independent Growth
- (2009) Giada Monami et al. AMERICAN JOURNAL OF PATHOLOGY
- Proepithelin is an autocrine growth factor for bladder cancer
- (2009) Francesca Lovat et al. CARCINOGENESIS
- Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease
- (2009) Sherryline Jogie-Brahim et al. ENDOCRINE REVIEWS
- Decorin is a novel antagonistic ligand of the Met receptor
- (2009) Silvia Goldoni et al. JOURNAL OF CELL BIOLOGY
- Decorin Suppresses Bone Metastasis in a Breast Cancer Cell Line
- (2009) Kentaro Araki et al. ONCOLOGY
- An Antimetastatic Role for Decorin in Breast Cancer
- (2008) Silvia Goldoni et al. AMERICAN JOURNAL OF PATHOLOGY
- Molecular Pathogenesis and Diagnostics of Bladder Cancer
- (2008) Anirban P. Mitra et al. Annual Review of Pathology-Mechanisms of Disease
- Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation
- (2008) X. Bi et al. CARCINOGENESIS
- The Type 1 Insulin-Like Growth Factor Receptor Pathway
- (2008) M. M. Chitnis et al. CLINICAL CANCER RESEARCH
- Decorin-Mediated Inhibition of Proliferation and Migration of the Human Trophoblast via Different Tyrosine Kinase Receptors
- (2008) D. Iacob et al. ENDOCRINOLOGY
- Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs
- (2008) Silvia Goldoni et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular pathogenesis of bladder cancer
- (2008) Margaret A. Knowles International Journal of Clinical Oncology
- Decorin Regulates Endothelial Cell Motility on Collagen I through Activation of Insulin-like Growth Factor I Receptor and Modulation of α2β1 Integrin Activity
- (2008) Lorna R. Fiedler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biological Functions of the Small Leucine-rich Proteoglycans: From Genetics to Signal Transduction
- (2008) Liliana Schaefer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Grb10/Nedd4-mediated multiubiquitination of the insulin-like growth factor receptor regulates receptor internalization
- (2008) Giada Monami et al. JOURNAL OF CELLULAR PHYSIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started